MONTEMURRO, LUCA
MONTEMURRO, LUCA
DIP. DI SCIENZE FARMACEUTICHE
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance
2023 Bortolotti, Sonia; Angelucci, Silvia; Montemurro, Luca; Bartolucci, Damiano; Raieli, Salvatore; Lampis, Silvia; Amadesi, Camilla; Scardovi, Annalisa; Nieddu, Giammario; Cerisoli, Lucia; Paganelli, Francesca; Chiarini, Francesca; Teti, Gabriella; Falconi, Mirella; Pession, Andrea; Hrelia, Patrizia; Tonelli, Roberto
MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma
2021 Raieli S.; Di Renzo D.; Lampis S.; Amadesi C.; Montemurro L.; Pession A.; Hrelia P.; Fischer M.; Tonelli R.
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
2022 Bartolucci D.; Montemurro L.; Raieli S.; Lampis S.; Pession A.; Hrelia P.; Tonelli R.
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
2022 Lampis S.; Raieli S.; Montemurro L.; Bartolucci D.; Amadesi C.; Bortolotti S.; Angelucci S.; Scardovi A.L.; Nieddu G.; Cerisoli L.; Paganelli F.; Valente S.; Fischer M.; Martelli A.M.; Pasquinelli G.; Pession A.; Hrelia P.; Tonelli R.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance | Bortolotti, Sonia; Angelucci, Silvia; Montemurro, Luca; Bartolucci, Damiano; Raieli, Salvatore; L...ampis, Silvia; Amadesi, Camilla; Scardovi, Annalisa; Nieddu, Giammario; Cerisoli, Lucia; Paganelli, Francesca; Chiarini, Francesca; Teti, Gabriella; Falconi, Mirella; Pession, Andrea; Hrelia, Patrizia; Tonelli, Roberto | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-15-00990.pdf |
| MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma | Raieli S.; Di Renzo D.; Lampis S.; Amadesi C.; Montemurro L.; Pession A.; Hrelia P.; Fischer M.; ...Tonelli R. | 2021-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Frontiers in Oncology 25 February 2021.pdf; file supplemenatari.zip |
| MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment | Bartolucci D.; Montemurro L.; Raieli S.; Lampis S.; Pession A.; Hrelia P.; Tonelli R. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-04421.pdf |
| The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma | Lampis S.; Raieli S.; Montemurro L.; Bartolucci D.; Amadesi C.; Bortolotti S.; Angelucci S.; Scar...dovi A.L.; Nieddu G.; Cerisoli L.; Paganelli F.; Valente S.; Fischer M.; Martelli A.M.; Pasquinelli G.; Pession A.; Hrelia P.; Tonelli R. | 2022-01-01 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | Lampis_et_al-2022-Journal_of_Experimental_&_Clinical_Cancer_Research.pdf; 19688410.zip |